FIELD: medicine. SUBSTANCE: life duration in months is calculated by formula as a linear combination of several variables which are morphological tumor parameters, in particular: histological variant, parenchymatous area, value for nuclear antigen expression in proliferating cells and intensity of oncogene-suppressor p53 labeling. The present innovation provides higher accuracy of detecting life duration, decreased quantity of calculated variables and possibility to apply it at planning the tactics of therapy and, also, in choosing therapy technique. EFFECT: higher efficiency of prediction. 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING SEROUS OVARIAN CARCINOMA PATIENTS SURVIVAL PERIOD IN CLIMACTERIC PERIOD AND POSTMENOPAUSE | 2005 |
|
RU2291435C1 |
METHOD FOR PREDICTING LIFE DURATION OF PATIENTS SUFFERING FROM CHOLANGIOGENIC HEPATIC CARCINOMA | 2001 |
|
RU2202957C1 |
METHOD FOR PREDICTING SURVIVAL PERIOD IN SEROUS OVARY CARCINOMA PATIENTS OF REPRODUCTIVE AGE | 2005 |
|
RU2290640C1 |
METHOD FOR PREDICTING THE RELAPSE OF SEROUS OVARIAN CANCER | 2005 |
|
RU2290078C1 |
PREDICTION METHOD OF LIFE DURATION IN PATIENTS WITH MESONEPHROID OVARIAN CARCINOMA | 2008 |
|
RU2357672C1 |
LIFE SPAN PREDICTION METHOD FOR PATIENTS SUFFERING FROM MUCINOUS OVARIAN CARCINOMA | 2008 |
|
RU2354303C1 |
METHOD FOR PREDICTION OF RECURRENT OVARIAN CARCINOMA | 2013 |
|
RU2530556C1 |
METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS RELAPSING OVARIAN CARCINOMA | 2005 |
|
RU2297788C1 |
METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH SEROSAL OVARIAN CANCER | 2005 |
|
RU2299018C1 |
METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS AND ENDOMETRIOID OVARIAN CARCINOMA | 2003 |
|
RU2263912C2 |
Authors
Dates
2003-06-27—Published
2001-08-27—Filed